JP3115445B2 - Whitening cosmetics - Google Patents
Whitening cosmeticsInfo
- Publication number
- JP3115445B2 JP3115445B2 JP05066212A JP6621293A JP3115445B2 JP 3115445 B2 JP3115445 B2 JP 3115445B2 JP 05066212 A JP05066212 A JP 05066212A JP 6621293 A JP6621293 A JP 6621293A JP 3115445 B2 JP3115445 B2 JP 3115445B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- present
- effect
- whitening
- gabob
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、皮膚安全性に優れ、色
黒の皮膚を予防する効果と、色黒の皮膚を速やかに淡色
化する効果を有する美白化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic having excellent skin safety, an effect of preventing dark-skinned skin, and an effect of rapidly lightening dark-skinned skin.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】日焼
けによる色黒の皮膚は、皮膚内に存在するチロシンがチ
ロシナーゼの作用により酸化されてメラニン色素とな
り、このメラニンが過剰に生成することに基因するとさ
れている。この色素沈着を予防あるいは治療すべく、従
来よりL−アスコルビン酸及びその誘導体、コロイド状
硫黄、過酸化水素、ハイドロキノン等を配合してなる美
白化粧料が提案されている。しかし、これらの美白化粧
料は、保存安定性が不充分であるか、あるいは美白効果
が充分に認められないものであったり、または、色黒の
皮膚を淡色化する効果を認められるが、皮膚安全性上に
問題が生じるものであって、優れた美白化粧料を得るこ
とは困難であった。2. Description of the Related Art The dark-skinned skin caused by sunburn is caused by the fact that tyrosine present in the skin is oxidized by the action of tyrosinase to form melanin pigment, and this melanin is excessively produced. Have been. In order to prevent or treat this pigmentation, there has been proposed a whitening cosmetic composition containing L-ascorbic acid and its derivatives, colloidal sulfur, hydrogen peroxide, hydroquinone and the like. However, these whitening cosmetics have insufficient storage stability, or do not have a sufficient whitening effect, or have an effect of lightening dark-skinned skin. This poses a problem in terms of safety, and it has been difficult to obtain an excellent whitening cosmetic.
【0003】そこで、本発明者は、表皮に過剰に存在
するメラニンを速やかに排除すること、新たに皮膚内
にメラニンが生成することを抑制すること、しかも、
皮膚安全性上に問題がないこと等を満足する美白化粧料
を目的として、鋭意研究した。その結果、本発明者は、
後記美白化粧料が、この目的を達成することを見いだ
し、本発明を完成した。[0003] Accordingly, the present inventor has sought to quickly eliminate melanin excessively present in the epidermis, suppress the production of new melanin in the skin, and
With the aim of providing a whitening cosmetic that satisfies no problem in skin safety, etc., intensive research was conducted. As a result, the inventor
The present inventors have found that the whitening cosmetics described below achieve this object, and have completed the present invention.
【0004】即ち、本発明は、γ−アミノ−β−ヒドロ
キシ酪酸とその塩の群から選ばれる少なくとも一種と、
リボ核酸、デオキシリボ核酸及びそれらの塩の群から選
ばれる一種とを配合することを特徴とする美白化粧料を
提供するものである。That is, the present invention provides at least one selected from the group consisting of γ-amino-β-hydroxybutyric acid and salts thereof,
An object of the present invention is to provide a whitening cosmetic comprising a mixture of ribonucleic acid, deoxyribonucleic acid and one selected from the group consisting of salts thereof.
【0005】尚、GABOBを単独で配合した皮膚化粧
料は、皮膚組織賦活作用による皮膚老化防止効果を有す
る(特開昭62−255405号公報)。以下、本発明
の構成について詳述する。[0005] Skin cosmetics containing GABOB alone have an effect of preventing skin aging by activating skin tissue (Japanese Patent Application Laid-Open No. 62-255405). Hereinafter, the configuration of the present invention will be described in detail.
【0006】本発明に用いるGABOBは公知の物質で
あって、脳動脈硬化症の治療剤として適用されており、
その化学特性は次の通りである。[0006] GABOB used in the present invention is a known substance and has been applied as a therapeutic agent for cerebral arteriosclerosis.
Its chemical properties are as follows:
【0007】[0007]
【表1】 [Table 1]
【0008】GABOBを苛性カリ、苛性ソーダ又は水
酸化カルシウム、水酸化マグネシウムで中和して得られ
たGABOBのカリウム塩、同ナトリウム塩、同カルシ
ウム塩、同マグネシウム塩はいずれも本発明の美白化粧
料に適用される。The potassium salt, sodium salt, calcium salt and magnesium salt of GABOB obtained by neutralizing GABOB with caustic potash, caustic soda or calcium hydroxide or magnesium hydroxide are all used as the whitening cosmetic of the present invention. Applied.
【0009】また、本発明に係わるリボ核酸、デオキシ
リボ核酸及びそれらの塩の群から選ばれる「核酸類」は
公知の物質であって、それらの塩類としてはリボ核酸ま
たはデオキシリボ核酸と、無機塩基または有機塩基とか
らなる塩が適用され、好ましくはリボ核酸またはデオキ
シリボ核酸のナトリウム塩、カリウム塩、特に好ましく
はリジン塩、アルギニン塩が適用されるThe "nucleic acids" selected from the group of ribonucleic acid, deoxyribonucleic acid and salts thereof according to the present invention are known substances, and their salts include ribonucleic acid or deoxyribonucleic acid, inorganic bases and A salt comprising an organic base is applied, preferably a sodium salt or a potassium salt of ribonucleic acid or deoxyribonucleic acid, particularly preferably a lysine salt or an arginine salt.
【0010】GABOB及びその塩は皮膚組織を賦活し
て、皮膚ターンオーバー速度を促進し、かつメラニンを
角質層と共に速やかに排除して色素沈着を淡色化、正常
化する効果を有する。[0010] GABOB and its salts have the effect of activating skin tissue, accelerating the turnover rate of the skin, and rapidly eliminating melanin together with the stratum corneum to lighten and normalize pigmentation.
【0011】本発明の美白化粧料中に配合せる上記「核
酸類」は、皮膚のメラニン形成能を抑制し、新たに色黒
の皮膚となることを予防する効果を有する。The above-mentioned "nucleic acids" to be added to the whitening cosmetic composition of the present invention have an effect of suppressing the melanin-forming ability of the skin and preventing the skin from becoming a new dark-skinned skin.
【0012】GABOBとその塩の群から選ばれた少な
くとも一種と、核酸類とを配合した美白化粧料は、相乗
効果によって優れた色素沈着改善効果、淡色化防止、肌
あれ防止効果、保湿効果等を発現する。本発明の美白化
粧料は、太陽光に曝された後の色黒になる以前の皮膚ま
たは色黒となった皮膚を対象として、特に皮膚生理学上
不安定となった皮膚に塗布し、皮膚刺激を生じることな
く、色黒の皮膚を淡色化することに於いて、顕著な効果
を呈するものである。A whitening cosmetic containing at least one selected from the group consisting of GABOB and its salt and a nucleic acid is excellent in a pigmentation improving effect, a lightening preventing effect, a skin roughening preventing effect, a moisturizing effect, etc. by a synergistic effect. Is expressed. The whitening cosmetic composition of the present invention is applied to skin before becoming dark or darkened after exposure to sunlight, particularly to skin that is unstable in skin physiology, and is intended to stimulate skin. It has a remarkable effect in lightening the dark skin without causing any coloration.
【0013】本発明者は、美白化粧料中に配合せる上記
構成物質の相乗効果を最大限度に発揮する配合割合に関
して探究した結果、(I)GABOB及びその塩、(I
I)核酸類のそれぞれの配合量の比率(重量比)が
(I):(II)=1:0.01〜10である場合が好ま
しく、本発明の目的とする優れた効果が認められた。The inventor of the present invention has investigated the proportions of the above-mentioned constituents to be incorporated in a whitening cosmetic composition in order to maximize the synergistic effect, and found that (I) GABOB and its salts, (I)
I) It is preferable that the ratio (weight ratio) of each compounding amount of the nucleic acids is (I) :( II) = 1: 0.01 to 10, and the excellent effect aimed at by the present invention was recognized. .
【0014】また、当該美白化粧料中のGABOB及び
核酸類の配合量は、総量を基準として(I)は0.05
〜3.0wt%、(II)は0.05〜3.0wt%あれ
ばよい。各々の配合量の下限未満では本発明の目的とす
る効果に充分ではなく、一方、上限を越えても、その増
加分に見合った効果の向上は望めないものである。The amount of GABOB and nucleic acids in the whitening cosmetic is 0.05% (I) based on the total amount.
-3.0 wt%, and (II) may be 0.05-3.0 wt%. If the amounts are less than the lower limits, the effects intended by the present invention are not sufficient. On the other hand, if the amounts exceed the upper limits, the effect corresponding to the increase cannot be expected.
【0015】本発明の美白化粧料には上記のほかに各種
油剤、湿潤剤、色素、香料、防腐剤、界面活性剤、顔
料、抗酸化剤等を本発明の目的を達する範囲内で適宜配
合することができる。[0015] In addition to the above, various oils, wetting agents, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, and the like are appropriately added to the whitening cosmetic of the present invention as long as the object of the present invention is achieved. can do.
【0016】[0016]
【実施例】以下、実施例にて本発明を説明する。尚、実
施例に先立ち(1)皮膚刺激試験、(2)角質層のター
ンオーバー速度測定試験、(3)皮膚色明度回復試験、
(4)美白実用試験の方法を記載する。The present invention will be described below with reference to examples. Prior to Examples, (1) skin irritation test, (2) stratum corneum turnover speed measurement test, (3) skin color brightness recovery test,
(4) Describe the method of practical whitening test.
【0017】(1)皮膚刺激試験 夏期の太陽光に6時間(1日3時間で2日間)曝された
被検者25名の前腕屈側部皮膚に、試料0.05gを直
径1.0cmの円型のリント布のついたパッチテスト用
絆創膏を用いて24時間閉塞貼付した後、次の評価基準
に従い、各試料について被検者25名の皮膚の状態を評
価判定した。判定結果は、絆創膏除去1時間後及び24
時間後のうち反応の強い方を採用し、評価が(±)以上
の人の数で示した。(1) Skin irritation test 0.05 g of a sample having a diameter of 1.0 cm was placed on the skin of the flexion side of the forearm of 25 subjects exposed to the sunlight of summer for 6 hours (3 hours a day for 2 days). After 24 hours of obstruction and application using a patch test patch with a circular lint cloth, the skin condition of 25 subjects was evaluated and determined for each sample according to the following evaluation criteria. The judgment results were 1 hour after bandage removal and 24 hours.
The one with the strongest response after time was adopted, and the number of people with an evaluation of (±) or more was indicated.
【0018】[0018]
【表2】 [Table 2]
【0019】(2)角質層のターンオーバー速度測定試
験 蛍光色素のダンシルクロリドを白色ワセリン中に5wt
%配合した軟膏を作り、被検者20名の前腕屈側部の皮
膚に24時間閉塞貼付し、角質層にダンシルクロリドを
浸透結合させる。その後同じ部位に1日2回(朝、夕)
被検試料を塗布し、毎日ダンシルクロリドの蛍光を調
べ、その蛍光が消滅するまでの日数を皮膚角質層のター
ンオーバー速度とした。測定結果は各被検者の日数の平
均値で示した。 尚、通常の皮膚角質層のターンオーバ
ー速度は、14〜16日である。(2) Test for measuring the turnover speed of the stratum corneum The fluorescent dye dansyl chloride was added to white vaseline in an amount of 5 wt.
% Ointment is prepared and adhered to the skin on the flexion side of the forearm of 20 subjects for 24 hours, and dansyl chloride is penetrated into the stratum corneum. Then twice a day at the same site (morning and evening)
The test sample was applied and the fluorescence of dansyl chloride was examined every day. The number of days until the fluorescence disappeared was defined as the turnover speed of the stratum corneum of the skin. The measurement results were shown as the average of the number of days for each subject. In addition, the turnover speed of the normal skin stratum corneum is 14 to 16 days.
【0020】(3)皮膚色明度回復試験 被試験者20名の背部皮膚にUV−B領域の紫外線を最
小紅班量の2倍量照射し、1週間の後、その照射部に試
料塗布部位と非塗布部位とを設定して各々の皮膚の基準
明度(Vo値、Vo’値)を測定した。引き続いて塗布
部位には試料を1日1回ずつ3カ月間連続塗布し、3,
8,13週間後の塗布部位及び非塗布部位の皮膚の明度
(Vn…値、Vn’…値)を測定して、次の評価基準に
より皮膚色の回復評価を実施した。尚、皮膚の明度(マ
ンセル表色系V値)は高速分光色彩計で測定して得られ
たX、Y、Z値より算出した。また、評価は被試験者2
0名の13週間後の評価値の平均値で示した。(3) Skin color lightness recovery test The back skin of the 20 test subjects was irradiated with ultraviolet rays in the UV-B region twice as much as the minimum erythema dose. The reference lightness (Vo value, Vo 'value) of each skin was measured by setting the and the non-application site. Subsequently, the sample was continuously applied to the application site once a day for three months.
The lightness (Vn... Value, Vn ′... Value) of the skin at the application site and the non-application site after 8 and 13 weeks was measured, and the evaluation of skin color recovery was performed according to the following evaluation criteria. The lightness (V value of Munsell color system) of the skin was calculated from X, Y, and Z values obtained by measuring with a high-speed spectral colorimeter. In addition, the evaluation
The average value of the evaluation values of 13 subjects after 13 weeks was shown.
【0021】[0021]
【表3】 [Table 3]
【0022】(4)美白実用試験 夏期の太陽光に3時間(1 日1.5時間で2日間)曝さ
れた被検者20名の前腕屈側部皮膚を対象として、左前
腕屈側部には太陽光に曝された日の翌日より、また、右
前腕屈側部には太陽光に曝された日の7日後より各々試
料を朝夕1回ずつ13週間連続塗布した。評価は、試料
を塗布した皮膚の部分が他の皮膚の部分より色白(淡色
化)となったと回答した被検者の数で示した。(4) Practical whitening test The left forearm flexed side skin of the forearm flexed skin of 20 subjects exposed to the sunlight of summer for 3 hours (1.5 hours a day for 2 days) On the right forearm flexion side, samples were applied once a day in the morning and evening for 13 weeks on the right forearm flexing side, respectively, 7 days after the day exposed to sunlight. The evaluation was indicated by the number of subjects who answered that the skin portion to which the sample was applied became lighter (lighter) than the other skin portions.
【0023】実施例1〜4、比較例1〜4(二層型ロー
ション) 表4の組成に於いて、表5左欄に示す通りにGABOB
及び核酸類の配合量を変えて、各々の二層型ローション
を調製した。 (1)組成Examples 1 to 4 and Comparative Examples 1 to 4 (two-layer type lotion) In the composition of Table 4, GABOB was used as shown in the left column of Table 5.
Each double-layer lotion was prepared by changing the amounts of the nucleic acids and nucleic acids. (1) Composition
【0024】[0024]
【表4】 [Table 4]
【0025】[0025]
【表5】 [Table 5]
【0026】(2)調製法 (A)、(B)成分を各々均一に溶解した後、(A)成
分と(B)成分を混合攪拌分散し、次いで容器に充填す
る。使用時には内容物を均一に振盪分散して使用する。(2) Preparation method After the components (A) and (B) are uniformly dissolved, the components (A) and (B) are mixed, dispersed by stirring, and then filled in a container. When used, the contents are shaken and dispersed uniformly.
【0027】(3)特性 これを試料として諸試験を実施した。その結果を表5の
右欄に示す。(3) Characteristics Various tests were carried out using this as a sample. The results are shown in the right column of Table 5.
【0028】表5に示すごとく、比較例1〜4の二層型
ローション基剤及びこの基剤に、GABOB及びその塩
と核酸類を各々単独で配合したローションでは、角質層
ターンオーバー速度がやや速くなり日数が減少する効果
が認められるが、皮膚色明度回復試験及び美白実用試験
に於いて充分なる効果は得られない。実施例1〜4の本
発明の美白化粧料は諸試験の評価がすべて良好である。As shown in Table 5, the two-layer type lotion bases of Comparative Examples 1 to 4 and the lotion in which GABOB and its salts and nucleic acids were individually added to the bases had slightly higher stratum corneum turnover rates. Although the effect of shortening the number of days can be recognized, sufficient effects cannot be obtained in the skin color brightness recovery test and the whitening practical test. The whitening cosmetics of the present invention of Examples 1 to 4 all have good evaluations in various tests.
【0029】実施例5〜9、比較例5〜7(スキンクリ
ーム) 実施例1と同様に、表6の組成に於いて表7左欄に示す
GABOB及び核酸類の配合量で後記の調製方法によっ
て各々のスキンクリームを調製した。Examples 5 to 9 and Comparative Examples 5 to 7 (skin cream) In the same manner as in Example 1, in the composition of Table 6, the following preparation method was carried out using the amounts of GABOB and nucleic acids shown in the left column of Table 7 To prepare each skin cream.
【0030】(1)組成(1) Composition
【0031】[0031]
【表6】 [Table 6]
【0032】(2)調製法 (A)、(B)成分を各々均一に加熱溶解して温度を8
0°Cにした後、(B)成分中に(A)成分を注入攪拌
混合する。次いで、攪拌しながら温度を30°C迄冷却
する。 (3)特性 諸試験を実施し、その結果を表7右欄に示した。(2) Preparation method The components (A) and (B) are each uniformly heated and dissolved to a temperature of 8
After the temperature is brought to 0 ° C., the component (A) is poured into the component (B) and mixed with stirring. Then, the temperature is cooled to 30 ° C. while stirring. (3) Characteristics Various tests were conducted, and the results are shown in the right column of Table 7.
【0033】[0033]
【表7】 [Table 7]
【0034】表7に示すごとく、比較例5〜7に対して
本発明の美白化粧料である実施例5〜9は諸試験に於い
てすべて良好な結果を示し、美白効果も優れていること
は明らかであった。As shown in Table 7, Examples 5 to 9, which are the whitening cosmetics of the present invention, show good results in various tests and excellent whitening effects as compared with Comparative Examples 5 to 7. Was evident.
【0035】[0035]
【発明の効果】以上、記載の如く、本発明の美白化粧料
は、皮膚安全性が高く、メラニン色素形成抑制効果と色
黒の皮膚を速やかに淡色化する効果を有することが明ら
かであり、特に太陽光等に曝された後、速やかに使用す
ることによって、更に一段と美白効果が向上することが
認められた。As described above, it is apparent that the whitening cosmetic of the present invention has high skin safety, has an effect of suppressing melanin pigment formation and an effect of rapidly lightening dark skin, as described above. In particular, it was recognized that the whitening effect was further improved by using the product immediately after exposure to sunlight or the like.
Claims (1)
塩の群から選ばれる少なくとも一種と、リボ核酸、デオ
キシリボ核酸及びそれらの塩の群から選ばれる一種とを
配合することを特徴とする美白化粧料。1. A whitening method comprising mixing at least one selected from the group consisting of γ-amino-β-hydroxybutyric acid and salts thereof and one selected from the group consisting of ribonucleic acids, deoxyribonucleic acids and salts thereof. Cosmetics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05066212A JP3115445B2 (en) | 1993-03-01 | 1993-03-01 | Whitening cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05066212A JP3115445B2 (en) | 1993-03-01 | 1993-03-01 | Whitening cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06256139A JPH06256139A (en) | 1994-09-13 |
JP3115445B2 true JP3115445B2 (en) | 2000-12-04 |
Family
ID=13309298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP05066212A Expired - Lifetime JP3115445B2 (en) | 1993-03-01 | 1993-03-01 | Whitening cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3115445B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3308433B2 (en) * | 1995-08-31 | 2002-07-29 | 株式会社資生堂 | Skin activating food |
-
1993
- 1993-03-01 JP JP05066212A patent/JP3115445B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH06256139A (en) | 1994-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69800170T2 (en) | System consisting of phosphonic acid derivatives and metabisulphite to stabilize ascorbic acid | |
JPH03153609A (en) | Skin-beautifying cosmetic | |
JP3115445B2 (en) | Whitening cosmetics | |
JPS649965B2 (en) | ||
JPH0363211A (en) | Cosmetic for fair skin and beauty | |
JP2684615B2 (en) | Skin cosmetics | |
JP3133508B2 (en) | Whitening agents and whitening cosmetics | |
JP3354768B2 (en) | Skin cosmetics | |
JP3378127B2 (en) | Whitening cosmetics | |
JPH0678223B2 (en) | Skin cosmetics | |
JPH0615465B2 (en) | Whitening cosmetics | |
JPH07112966B2 (en) | Skin cosmetics | |
JPH0363207A (en) | Skin cosmetic | |
JP2511815B2 (en) | Whitening cosmetics | |
JP2671244B2 (en) | Whitening cosmetics | |
JP2744485B2 (en) | Whitening cosmetics | |
JPH06100429A (en) | Skin beautifying cosmetic | |
JP2511816B2 (en) | Whitening cosmetics | |
JPH05345716A (en) | Skin cosmetic | |
JPS60116616A (en) | Cosmetic | |
JPH03153610A (en) | Skin-beautifying cosmetic | |
JPH05194178A (en) | Skin-beautifying cosmetic | |
RU2252015C1 (en) | Preparation for biological skin rejuvenation | |
JP3195835B2 (en) | Melanin production inhibitor and external preparation for skin | |
JPH0615466B2 (en) | Whitening cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090929 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100929 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110929 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120929 Year of fee payment: 12 |